Everolimus Slows Disease Progression in Advanced Kidney Cancer Patients Science Daily (press release) Sep. 27, 2013 — The first Phase II study to investigate the use of the anti-cancer drug, everolimus, for the initial treatment of advanced papillary kidney cancer has shown that it is successful in slowing or preventing the spread of the disease ... |